Improving Vascular Care for the Disadvantaged: Is There Hope on the Horizon?

In this important VIVA24 session, experts examined variations in care across patient populations, combatting biases, and how we can move toward a better future for all patients.

Moderator: Niten Singh, MD

Panel: Joshua Beckman, MD;
Donna Buckley, MD;
Bryan Fisher, MD;
Elina Quiroga, MD, MPH;
Vincent L. Rowe, MD;
Margaret Tracci, MD, JD

Originally recorded November 5, 2024.

2024 Late-Breaking Clinical Trials

Two-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Late-Breaking Clinical Trial presented by Dr. Brian DeRubertis at VIVA24

Moderator: Eric A. Secemsky, MD, MSc

Panel: J. Fritz Angle

Read More ...

Late-Breaking Clinical Trial presented by Dr. Brian DeRubertis at VIVA24

Moderator: Eric A. Secemsky, MD, MSc

Panel: J. Fritz Angle, MD; Iris Baumgartner, MD; Marc P. Bonaca, MD, MPH; Patrick Geraghty, MD; Misty Humphries, MD; Brian Pullin; Mehdi Shishehbor, DO, MPH, PhD

Originally recorded November 4, 2024.

Read Less
Endovascular PAD Treatment With Drug-Eluting Devices in a Registry Focused on Underrepresented Minorities and Women: 12-Month Clinical Results From the First 500 ELEGANCE Registry Patients

Late-Breaking Clinical Trial presented by Dr. Jay Giri at VIVA24

Moderator: Joshua Beckman, MD

Panel: Misty Humphries, MD; Zola N’Dandu

Read More ...

Late-Breaking Clinical Trial presented by Dr. Jay Giri at VIVA24

Moderator: Joshua Beckman, MD

Panel: Misty Humphries, MD; Zola N’Dandu, MD; Krina Patel; Vincent L. Rowe, MD; Eric A. Secemsky, MD, MSc; Nora Tabori, MD

Originally recorded November 5, 2024.

Read Less
Healthcare Resource Utilization and Outcomes Among Patients With Intermediate-Risk PE Treated With Computer-Assisted Vacuum Thrombectomy vs Other Treatment Modalities

Late-Breaking Clinical Trial presented by Dr. Parag Patel at VIVA24

Moderator: Ehrin Armstrong, MD

Panel: Bryan Fisher, MD; Raghu Kolluri, MD

Read More ...

Late-Breaking Clinical Trial presented by Dr. Parag Patel at VIVA24

Moderator: Ehrin Armstrong, MD

Panel: Bryan Fisher, MD; Raghu Kolluri, MD, MS; Jun Li, MD; Lindsay Machan, MD; Misti Malone, PhD; Niten Singh, MD; Peter A. Soukas, MD

Originally recorded November 4, 2024.

Read Less

Featured Conference Content

VIVA23 ATLAS Award Presentation & Lecture

Award presenter: Niten Singh, MDATLAS award recipient: Peter A. Schneider, MD

After accepting the award, Dr. Schneider presents his ATLAS

Read More ...

Award presenter: Niten Singh, MD
ATLAS award recipient: Peter A. Schneider, MD

After accepting the award, Dr. Schneider presents his ATLAS lecture titled Passionate About Vascular Care: "Growing in an Era of Change and Challenge."

This presentation was recorded on October 31, 2023, during the VIVA conference at Wynn Las Vegas.

Read Less
Wound Assessment and Outcomes in the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit BTK™ Drug-Eluting Resorbable Scaffold

Late-Breaking Clinical Trial presented by Dr. Raghu Kolluri at VIVA23

Moderator: Parag J. Patel, MD, MS

Panel: Subhash Banerjee, MD; Jeff

Read More ...

Late-Breaking Clinical Trial presented by Dr. Raghu Kolluri at VIVA23

Moderator: Parag J. Patel, MD, MS

Panel: Subhash Banerjee, MD; Jeff Carr, MD; Daniel Clair, MD; Caitlin W. Hicks, MD, MS; Kayla M. Scott, PhD; Jordan R. Stern, MD

Recorded October 31, 2023.

Read Less
5-Year Outcomes of the Gore® Viabahn® Endoprosthesis for the Treatment of Complex Femoropopliteal Lesions in a Japanese Population

Late-Breaking Clinical Trial presented by Dr. Osamu Iida at VIVA23

Moderator: Sean Lyden, MD

Panel: Marc Bonaca, MD, MPH

Read More ...

Late-Breaking Clinical Trial presented by Dr. Osamu Iida at VIVA23

Moderator: Sean Lyden, MD

Panel: Marc Bonaca, MD, MPH; Kenneth Cavanaugh, PhD; Venita Chandra, MD; Misty Humphries, MD; Constantino Pena, MD; Eric A. Secemsky, MD, MSc

Recorded October 31, 2023.

Read Less
Pharmacotherapy in Preventing and Treating Thromboembolic Disease in Active Malignancy

Dr. Yogen Kanthi presents "Pharmacotherapy in Preventing and Treating Thromboembolic Disease in Active Malignancy" at The VEINS 2023 as part

Read More ...

Dr. Yogen Kanthi presents "Pharmacotherapy in Preventing and Treating Thromboembolic Disease in Active Malignancy" at The VEINS 2023 as part of the session "All About Blood Clots"

This presentation was recorded on Saturday, October 28, 2023 at Wynn Las Vegas.

Read Less
2022 ATLAS Lecture

Dr. Michael Dake presents the first annual ATLAS Lecture titled "Preparing for the Future: Building a Learning Environment While Addressing

Read More ...

Dr. Michael Dake presents the first annual ATLAS Lecture titled "Preparing for the Future: Building a Learning Environment While Addressing Workforce Shortages."

The ATLAS (A Teacher, Leader, And Scholar) Award celebrates the career and impact of physicians who have distinguished themselves as scholars and leaders in their respective vascular fields. They have committed their careers to advancing the care of patients with vascular disorders, and they have taught countless numbers of physicians techniques to expand care across the United States and the world. The VIVA Foundation was proud to honor Dr. Dake as the 2022 ATLAS Award recipient, and we thank him for his innumerable contributions to the field of interventional radiology as a practitioner and educator.

This presentation was recorded on Tuesday, November 1, 2022 at Wynn Las Vegas.

Read Less

Featured Webinars

Bridging the NIVL Evidence Gap: A Conversation With Authors of the VIVA/AVF/AVLS Consensus Statement

Over the last two years, The VIVA Foundation, the American Venous Forum (AVF), and the American Vein and Lymphatic Society

Read More ...

Over the last two years, The VIVA Foundation, the American Venous Forum (AVF), and the American Vein and Lymphatic Society (AVLS) have collaborated to publish a consensus statement on nonthrombotic iliac vein lesions, seeking to address the challenges posed by limited research and to offer clarity to practitioners. A selection of these authors took a closer look at the statements and offered additional insights on the paper’s methodology.

Originally broadcast October 1, 2024.

Read Less
Advances in Endovascular Treatment of CLTI: Insights From the LIFE-BTK Trial

Bioresorbable scaffolds represent a novel option for treatment of below-the-knee lesions that offer advantages over permanent devices. New data show

Read More ...

Bioresorbable scaffolds represent a novel option for treatment of below-the-knee lesions that offer advantages over permanent devices. New data show not only efficacy and safety parity with angioplasty balloon angioplasty, but LIFE-BTK also demonstrated that scaffolds lower BTK limb events.

In this 1-hour webinar, LIFE-BTK trial leaders, a representative from the FDA, and a wound care expert shared their perspectives on the trial, its design, and the ramifications of its findings.

Originally broadcast March 14, 2024.

Funded by Abbott

Read Less
The End of the Paclitaxel Debate: Lessons Learned and What Lies Ahead

VIVA board members, field experts, and an FDA representative examined the evolution of the paclitaxel controversy and key takeaways for the future.

Originally broadcast July 17, 2023.

Best Endo, Best Surgery, or Both for CLTI: How to Interpret the Results from the BEST-CLI and BASIL-2 Trials

Moderators: Eric A. Secemsky, MD, MSc; Saher Sabri, MD; Peter A. Schneider, MD

Panelists: Joshua A. Beckman, MD; Venita Chandra

Read More ...

Moderators: Eric A. Secemsky, MD, MSc; Saher Sabri, MD; Peter A. Schneider, MD

Panelists: Joshua A. Beckman, MD; Venita Chandra, MD; Alik Farber, MD; Matthew Menard, MD; Andrew Bradbury, MD

Originally broadcast June 28, 2023

Read Less
Putting Data Into Practice: The Best-CLI Trial

The much-anticipated results from the BEST-CLI trial have provided side-by-side comparison of surgical and endovascular care of patients with critical limb-threatening ischemia (CLTI).

Originally broadcast December 8, 2022

Two Extremes: The Role of Radial Access in CLTI Intervention and When to Use Retrograde SFA Access

Presenter: George Adams, MD
Moderator: Ehrin Armstrong, MD
Panelists: Bryan Fisher, MD; Steve Henao, MD; Jun Li, MD

Originally broadcast May 27, 2021

How I Get Tibiopedal Access With Efficiency and Accuracy: Tips and Tricks

Presenter: Brian DeRubertis, MD
Moderator: Ehrin Armstrong, MD
Panelists: Bryan Fisher, MD; Steve Henao, MD; Jun Li, MD

Originally broadcast May 27, 2021

Wire Selection and Wire Escalation for Infrapopliteal CTOs

Presenter: Lieven Maene, MD
Moderator: Ehrin Armstrong, MD
Panelists: Bryan Fisher, MD; Steve Henao, MD; Jun Li, MD

Originally broadcast May 27, 2021

Panel Discussion: Access and Crossing for Complex Lesions Part 1

Dr. Ehrin Armstrong leads Drs. George Adams, Bryan DeRubertis, Bryan Fisher, Steve Henao, Jun Li, and Lieven Maene in a

Read More ...

Dr. Ehrin Armstrong leads Drs. George Adams, Bryan DeRubertis, Bryan Fisher, Steve Henao, Jun Li, and Lieven Maene in a panel discussion about the first three presentations in this CLTI session.

Originally broadcast May 27, 2021

Read Less
Tibiopedal Access with Re-Entry

Presenter: Shant Vartanian, MD
Moderator: Ehrin Armstrong, MD
Panelists: Robert Beasley, MD; Bryan Fisher, MD; Steve Henao, MD; Jun Li, MD

Originally broadcast May 27, 2021

Radial Access for Complex Disease

Presenter: Jun Li, MD
Moderator: Ehrin Armstrong, MD
Panelists: Robert Beasley, MD; Bryan Fisher, MD; Steve Henao, MD; Shant Vartanian, MD

Originally broadcast May 27, 2021

Below-the-Ankle Pedal Arch Reconstruction

Presenter: Robert Beasley, MD
Moderator: Ehrin Armstrong, MD
Panelists: Bryan Fisher, MD; Steve Henao, MD; Jun Li, MD; Shant Vartanian, MD

Originally broadcast May 27, 2021

What Is Your Guide Wire Algorithm? Key Strategies for CLTI Procedures

Sponsored by Abbott Vascular

Presenters: Ehrin Armstrong, MD;
Brian DeRubertis, MD

Originally broadcast May 27, 2021